Cheng I K, Chan P C, Chan M K
Department of Medicine, University of Hong Kong, Queen Mary Hospital.
Am J Nephrol. 1989;9(2):155-61. doi: 10.1159/000167956.
The characteristics of 5 patients who developed tuberculous peritonitis while receiving long-term peritoneal dialysis (PD) are presented. There were 2 males and 3 females. 3 patients were on intermittent and 2 were on continuous ambulatory peritoneal dialysis when tuberculous peritonitis was first diagnosed. None of the patients had recently received immunosuppression therapy or were diabetics. The clinical presentations were similar to other forms of peritonitis complicating PD except for a more insidious onset. As extraperitoneal involvement and peritoneal lymphocytosis were rarely present, the diagnosis was mainly dependent on the direct demonstration of Mycobacterium tuberculosis with smear (1 patient) and culture (4 patients). In 1 patient with a pleuroperitoneal communication, the diagnosis was made by pleural biopsy and a positive response to antituberculous therapy. All patients responded to treatment with a combination of three antituberculous drugs which included streptomycin, isoniazid, rifampicin and pyrazinamide. Two patients were transferred to hemodialysis. In 3 patients, peritoneal dialysis was continued. Peritoneal clearance and ultrafiltration capacity were unchanged for up to 16 months after treatment in 2 patients who continued peritoneal dialysis but was reduced by 30 and 50%, respectively, in the remaining patient. Only 1 patient died, but her death was not directly related to tuberculous peritonitis. It was concluded that with a high index of suspicion and early institution of treatment, tuberculous peritonitis complicating PD can be successfully treated with low mortality and without compromising the dialysis capacity of the peritoneal membrane.
本文介绍了5例在长期接受腹膜透析(PD)时发生结核性腹膜炎的患者特征。其中男性2例,女性3例。首次诊断结核性腹膜炎时,3例患者采用间歇性腹膜透析,2例采用持续性非卧床腹膜透析。所有患者近期均未接受免疫抑制治疗,也均非糖尿病患者。临床表现与其他并发于PD的腹膜炎形式相似,只是起病更为隐匿。由于很少出现腹膜外受累及腹膜淋巴细胞增多,诊断主要依赖于通过涂片(1例患者)和培养(4例患者)直接发现结核分枝杆菌。1例存在胸膜腹膜通道的患者,通过胸膜活检及抗结核治疗的阳性反应得以确诊。所有患者对包括链霉素、异烟肼、利福平及吡嗪酰胺在内的三种抗结核药物联合治疗均有反应。2例患者转为血液透析。3例患者继续腹膜透析。继续腹膜透析的2例患者在治疗后长达16个月腹膜清除率和超滤能力未变,但其余1例患者的腹膜清除率和超滤能力分别降低了30%和50%。仅1例患者死亡,但其死亡与结核性腹膜炎无直接关系。结论是,只要高度怀疑并尽早开始治疗,并发于PD的结核性腹膜炎能够成功治疗,死亡率低,且不影响腹膜的透析能力。